David Schwartz
Principal investigator, leads CELL IDX, INC..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$2.5MFederal grants as PI4 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $2.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 19, 2017 | NIH | SBIR Phase II Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay | $141K | CELL IDX, INC. |
| May 6, 2016 | NIH | SBIR Phase II Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay | $507K | CELL IDX, INC. |
| Sep 28, 2015 | NIH | SBIR Phase II Development of a Multi-Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay | $612K | CELL IDX, INC. |
| Sep 25, 2015 | NIH | SBIR Phase II Development of a Multi Panel Multiplex Immunofluorescence Breast Cancer Immunophenotyping Assay | $1.3M | CELL IDX, INC. |
Peer ranks
Federal funding#847
Awards as PI#643
Patents#505
Companies
- CELL IDX, INC.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.